Clinical Trial Update: A Study of KX2-391 With Paclitaxel in Patients With Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating KX2-391 in combination with paclitaxel for gastric cancer and breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Gastric Cancer

Drugs mentioned

• KX2-391
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Hanmi Pharmaceutical Company Limited | Conditions: Unspecified Adult Solid Tumor, Protocol Specific, Gastric Cancer | Phase 1, Phase 2 | Status: UNKNOWN